Cervical carcinoma is the third most common cancer in women, and the seventh overall, with an estimated 530,000 new cases in 2008 Cervical carcinoma can be categorized into subtypes according to histological classification, of which invasive squamous cell carcinoma (SCC) is the most common, accounting for about 80% of invasive cancer in the cervix And other subtypes including adenocarcinoma of uterine cervix are considered as distinct disease entities against SCC from epidemiology to clinical manifestations Squamous cell carcinoma-related antigen (SCC-Ag), which also known as TA-4 (tumor antigen), may be the tumor marker of
No takes yet. Share an insight, caveat, or question.
An et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: